Overview

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will explore HBV kinetics in CHB patients during the first 24 weeks of treatment with telbivudine
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Adefovir
Adefovir dipivoxil
Telbivudine